Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nirali N Shah

Showing results (1-10 of 227) with videos related to

Pageof 23
Sort By:
Blood|January 31, 2020
The one-two punch (of CAR T cells)Nirali N Shah
Current Drug Targets|September 6, 2016
Antibody Based Therapies in Acute LeukemiaNirali N Shah
Hematology. American Society of Hematology. Education Program|December 9, 2023
Long-term follow-up of CD19-CAR T-cell therapy in children and young adults with B-ALLRebecca Epperly, Nirali N Shah
Nature Medicine|November 24, 2020
Using single-cell analysis to predict CAR T cell outcomesSneha Ramakrishna, Nirali N Shah
The Lancet. Haematology|September 9, 2022
CD19 CAR T cells for infants and young childrenHaneen Shalabi, Nirali N Shah
The Lancet. Haematology|April 24, 2021
Surviving the storm: critical care outcomes of chimeric antigen receptor T-cell therapyJanhavi Athale, Nirali N Shah
Blood|September 26, 2024
CARdinal signs of variant ICANSJuliane Gust, Nirali N Shah
Cell Reports. Medicine|May 18, 2022
CD70 CAR T cells in AML: Form follows functionJustin Mirazee, Nirali N Shah
Blood Advances|September 23, 2025
Gene-edited CAR T cells: going the distance in B-ALLJohn A Ligon, Nirali N Shah
Blood Advances|January 26, 2021
CAR T cells better than BiTEsJohn C Molina, Nirali N Shah
Pageof 23

Showing results (1-10 of 227) with videos related to

Sort By:
Pageof 23
Blood|January 31, 2020
The one-two punch (of CAR T cells)Nirali N Shah
Current Drug Targets|September 6, 2016
Antibody Based Therapies in Acute LeukemiaNirali N Shah
Hematology. American Society of Hematology. Education Program|December 9, 2023
Long-term follow-up of CD19-CAR T-cell therapy in children and young adults with B-ALLRebecca Epperly, Nirali N Shah
Nature Medicine|November 24, 2020
Using single-cell analysis to predict CAR T cell outcomesSneha Ramakrishna, Nirali N Shah
The Lancet. Haematology|September 9, 2022
CD19 CAR T cells for infants and young childrenHaneen Shalabi, Nirali N Shah
The Lancet. Haematology|April 24, 2021
Surviving the storm: critical care outcomes of chimeric antigen receptor T-cell therapyJanhavi Athale, Nirali N Shah
Blood|September 26, 2024
CARdinal signs of variant ICANSJuliane Gust, Nirali N Shah
Cell Reports. Medicine|May 18, 2022
CD70 CAR T cells in AML: Form follows functionJustin Mirazee, Nirali N Shah
Blood Advances|September 23, 2025
Gene-edited CAR T cells: going the distance in B-ALLJohn A Ligon, Nirali N Shah
Blood Advances|January 26, 2021
CAR T cells better than BiTEsJohn C Molina, Nirali N Shah
Pageof 23